How many email patterns does Palvella Therapeutics use?

Palvella Therapeutics uses 2 known email patterns.

What domain does Palvella Therapeutics use for work emails?

Palvella Therapeutics uses palvellatx.com for work email addresses.

Most Common Email Formats at Palvella Therapeutics

Palvella Therapeutics's most common email format is First.Last@palvellatx.com (ex. John.Doe@palvellatx.com), used for 98% of palvellatx.com addresses. Palvella Therapeutics uses 2 email patterns.

@palvellatx.com

2 patterns

Format	Example	Share of palvellatx.com
First.Last@palvellatx.comMost common	John.Doe@palvellatx.com	98%
First@palvellatx.com	John@palvellatx.com	2%

Frequently Asked Questions

What does Palvella Therapeutics do?

Palvella Therapeutics was founded in 2015 and operates in the Biotechnology Research industry, alongside similar companies like BioMotiv, Verrica Pharmaceuticals and Nomis Solutions. You can visit palvellatx.com. Explore Palvella Therapeutics's company overview page for more information.

What is Palvella Therapeutics's email address format?

Palvella Therapeutics's email format typically follows the pattern of First.Last@palvellatx.com; this email format is used 98% of the time. Other contacts within LeadIQ's database had email formats such as First@palvellatx.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Palvella Therapeutics have currently?

Palvella Therapeutics has approximately 59 employees as of October 2026. Key team members to contact include Chief Executive Officer: W. K., Vice President Of Investor Relations And Corporate Affairs: M. N. and Vp Of R&d And Corporate Strategy: J. M. For more team information and contact data, explore Palvella Therapeutics's employee directory with LeadIQ.

Palvella Therapeutics Email Format

Biotechnology ResearchPennsylvania, United States51-200 Employees

Palvella Therapeutics is a clinical-stage biotechnology company based in Wayne, Pennsylvania, focused on developing therapies for serious, rare genetic skin diseases and vascular malformations for which there are no FDA-approved treatments. The company is building a broad pipeline around its QTORIN platform, concentrating on lifelong skin conditions with limited or no existing therapies. Its lead candidate, QTORIN 3.9% rapamycin anhydrous gel, is in clinical development for microcystic lymphatic malformations and cutaneous venous malformations.

It is also advancing QTORIN pitavastatin for disseminated superficial actinic porokeratosis. In 2026 Palvella presented clinical results from its QTORIN rapamycin program at the ISSVA World Congress 2026 in Philadelphia and has engaged with industry events, including the Goldman Sachs Global Healthcare Conference. Palvella was recognized as Healthcare & Life Sciences Company of the Year at the PACT Ecosystem Awards in 2026.

Most Common Email Formats at Palvella Therapeutics

@palvellatx.com

Need a specific person's email?

Frequently Asked Questions

What does Palvella Therapeutics do?

What is Palvella Therapeutics's email address format?

How many employees does Palvella Therapeutics have currently?

Palvella Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at Palvella Therapeutics

@palvellatx.com

Need a specific person's email?

Frequently Asked Questions

What does Palvella Therapeutics do?

What is Palvella Therapeutics's email address format?

How many employees does Palvella Therapeutics have currently?

Palvella Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.